Amgen's Denosumab Approved for Cancer Patients
The FDA has approved Amgen's osteoporosis drug denosumab for use by cancer patients with solid tumors whose disease has metastasized to their bones. The indication to prevent complications such as fractures and bone pain among those patients could boost the drug's sales by billions. Continue reading Amgen's Denosumab Approved for Cancer Patients Amgen's Denosumab Approved for Cancer Patients originally appeared on DailyFinance on Fri, 19 Nov 2010 13:24:00. Filed Under: Company News , Health Care , Novartis , Amgen , Stocks in the News Permalink | Tweet this! | Comments
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here